Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
Public ClinicalTrials.gov record NCT02556203. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Global Multicenter, Open-label, Randomized, Event-driven, Active-controlled Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement (TAVR) to Optimize Clinical Outcomes
Study identification
- NCT ID
- NCT02556203
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 1,653 participants
Conditions and interventions
Conditions
Interventions
- Rivaroxaban (Xarelto, BAY59-7939) Drug
- Acetylsalicylic Acid (ASA) Drug
- Clopidogrel Drug
- Vitamin K antagonist (VKA) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 15, 2015
- Primary completion
- Nov 26, 2018
- Completion
- Nov 26, 2018
- Last update posted
- Jan 12, 2020
2015 – 2018
United States locations
- U.S. sites
- 31
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Los Angeles | California | 90048-0750 | — |
| Not listed | Washington D.C. | District of Columbia | 20010 | — |
| Not listed | Clearwater | Florida | 33756 | — |
| Not listed | Jacksonville | Florida | 32209 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Evanston | Illinois | 60201 | — |
| Not listed | West Des Moines | Iowa | 50266 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Minneapolis | Minnesota | 55407 | — |
| Not listed | Kansas City | Missouri | 64111 | — |
| Not listed | Morristown | New Jersey | 07962 | — |
| Not listed | Manhasset | New York | 11030-3876 | — |
| Not listed | New York | New York | 10029 | — |
| Not listed | Roslyn | New York | 11576 | — |
| Not listed | Winston-Salem | North Carolina | 27157-1082 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Wilkes-Barre | Pennsylvania | 18711-3752 | — |
| Not listed | Houston | Texas | 77030-1501 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Plano | Texas | 75093 | — |
| Not listed | Temple | Texas | 76508 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
| Not listed | Falls Church | Virginia | 22042-3300 | — |
| Not listed | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02556203, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02556203 live on ClinicalTrials.gov.